Urology at Icahn School of Medicine at Mount Sinai

Leads a grant in this department

6 contact PIs of these awards, by the funding they lead. Other principal investigators on an award are listed with it and under Co-investigators.

1. Goutam Chakraborty

   Leads 2 awards · $792,949

   • 5R01CA274967-02Department: NIH department code

     Functional Characterization and Development of Therapeutic Paradigms for DNA Damage Repair (DDR)-deficient Lethal Prostate Cancer

     Principal investigators: Goutam Chakraborty (contact PI), Nagavarakishore Pillarsetty, Vladimir Ponomarev

     $678,271

     award amount
   • 3R01CA274967-02S1Department: NIH department code

     Functional Characterization and Development of Therapeutic Paradigms for DNA Damage Repair (DDR)-deficient Lethal Prostate Cancer

     Principal investigators: Goutam Chakraborty (contact PI), Nagavarakishore Pillarsetty, Vladimir Ponomarev

     $114,678

     award amount

2. Nina Bhardwaj

   Leads 1 award · $668,229

   • 5R01CA249175-05Department: NIH department code

     Dissecting myeloid cell-mediated resistance to immune checkpoint blockade in bladder cancer

     Principal investigators: Nina Bhardwaj (contact PI), Matthew Galsky

     $668,229

     award amount

3. Amir Horowitz

   Leads 1 award · $637,395

   • 5R01CA269954-02Department: NIH department code

     HLA-E and NKG2A define a novel immune checkpoint axis in non-muscle-invasive bladder cancer

     Principal investigators: Amir Horowitz (contact PI), John Sfakianos

     $637,395

     award amount

   Also a principal investigator on 5R21CA274148-02, led by John Sfakianos.

4. David Mulholland

   Leads 1 award · $237,023

   • 1R21CA286309-01Department: NIH department code

     Targeting the Androgen Receptor to Sensitize Bladder Cancer to Immune Check Point Blockade.
     $237,023

     award amount

5. Juan Martin Arriaga

   Leads 1 award · $192,456

   • 5K22CA258806-03Department: NIH department code

     Identification of therapeutic vulnerabilities in prostate cancer bone metastasis
     $192,456

     award amount

6. John Sfakianos

   Leads 1 award · $187,642

   • 5R21CA274148-02Department: NIH department code

     Identifying novel resistance mechanisms in non-muscle invasive bladder cancer treated with Bacillus Calmette-Guerin (BCG)

     Principal investigators: John Sfakianos (contact PI), Amir Horowitz

     $187,642

     award amount

   Also a principal investigator on 5R01CA269954-02, led by Amir Horowitz.

Co-investigators

Named as principal investigators on these awards, which someone else leads. They may belong to another department or institution: their own, below, comes from the awards they lead.

• Nagavarakishore Pillarsetty

  Co-investigator on 5R01CA274967-02, led by Goutam Chakraborty; 3R01CA274967-02S1, led by Goutam Chakraborty

  From the FY2024 awards this person leads

  • Memorial Sloan Kettering Cancer Center (no department on record, 1 award)

• Vladimir Ponomarev

  Co-investigator on 5R01CA274967-02, led by Goutam Chakraborty; 3R01CA274967-02S1, led by Goutam Chakraborty

  From the FY2024 awards this person leads

  • Memorial Sloan Kettering Cancer Center (no department on record, 1 award)

• Matthew Galsky

  Co-investigator on 5R01CA249175-05, led by Nina Bhardwaj

  From the FY2024 awards this person leads

  • Icahn School of Medicine at Mount Sinai (no department on record, 1 award)